220 likes | 387 Views
Special features of nerves:. Generation and conduction of electric signal Special contact with orther neurons or the innervated organs. Neurotransmitters. Nerve terminal. Nerve terminal. Axonal t ransport (enzymes for synthesis). Synthesis. Store. Release. uptake.
E N D
Special features of nerves: • Generation and conduction of electric signal • Special contact with orther neurons or the innervated organs
Nerve terminal Nerve terminal Axonal transport (enzymes for synthesis) Synthesis Store Release uptake enzymes Inactivation Postsynaptic receptors Second messenger ion channels
Cholinergic neurons • Neuromuscular juction • Autonomic preganglionic fibers • Parasympathetic postganglionic fibers- heart, glands, smooth muscle • Central nervous system
66 – 70 KDa • Immunohistochemical mapping of cholinergic neurons • Cytoplasmic • Not rate–limiting
[choline]plasma ~ 10 mM • „low-affinity” choline uptake • KM>10 µM - in all tissues • „high affinity” choline uptake • Na+-dependent • KM 1-5 µM • in cholinergic neurons • inhibitor: hemicholinium
Uptake of acetylcholine into vesicles transport inhibitor ~ 2000 molecules of ACh plus ATP
Cholinergic receptors Muscarinic Nicotinic Postganglionic parasympathetic nerve endings Neuromuscular juction Central nervous system CURARE ATROPINE Molecular mechanism: PLC activation, [Ca]; á, Activation of K+-channels Molecular mechanism: Na+, K+-channels
Receptors: Nicotinic • Ionotropic • Striatal muscle • Na+K+ permeability • Resting muscle tone • Miniature end-plate potential • Membran depol. • Ca2+ from SR • D-tubocuranine • Competitive inhibitor • CNS
Neuromuscular junction a-bungarotoxin - obtained from the venom of an Indian snake - specifically blocksmuscular nicotinic receptors.
Receptor: Muscarinic • 7 transmembrane G Protein receptor • M1 – Gq – PIP2hydrolysis • Regulation of transmitter release
Receptor: Muscarinic • 7 transmembrane G protein receptor • M2 • – heart • K+ channel activation • Hyperpolarisation • Bradycardia • Giadenylate cyclase inhibition
Receptor: Muscarinic • 7 transmembrane G Protein receptor • M3 • – Gastro-intestinal tract, Gq - Ca2+á • Smooth muscle contraction • Secretion stimulation • Inhibitor: atropin
Acetylcholine esterase • Synaptic • Specific for ACh
Pseudocholinesterase • In the plasma • function unknown • Hydrolysis other esters • Short-lasting muscle relaxants Suxamethonium
Acetylcholine bound to the active site of acetylcholinesterase. This is the enzyme-substrate (ES) complex. The the bond between the choline (left side) and acetate part (right side) of the molecule has been split. Choline and acetate will leave the enzyme and it will be ready to accept another acetylcholine molecule. 16 mmol / mg / min
Cholinesterase inhibitors -Diagnostic test Myasthenia gravis Autoimmune disease Antibody against nicotinic receptors -Myasthenia gravis • therapy • physostigmin, neostigmin -Eye drops • Glaucoma
Diisopropyl-flurophosphate (DFP) Reversible inhibitors: neostigmine, physostigmine, gallimine Irreversible inhibitors: organic phosphates, pesticides chemical warfare